Skip to content
Netherlands Society of Gene and Cell Therapy

Netherlands Society of Gene and Cell Therapy

  • About
    • History
    • Mission
    • Board Members
    • Committees
    • Honorary Members
  • Education
    • Gene Therapy Basics
    • Cell Therapy Basics
    • Antisense Oligonucleotide Therapy Basics
    • Approved Therapies
  • Research
    • Academic Research on Gene and Cell Therapy in The Netherlands
    • Greiner Award
    • NVGCT Outstanding Achievement Award
      • 2021 NVGCT Outstanding Achievement Award
      • 2020 NVGCT Outstanding Achievement Award
      • 2019 NVGCT Outstanding Achievement Award
    • Research News
    • Human Gene Therapy
    • Other Journals
    • Useful Links
    • Research Image Gallery
    • Research vacancies
  • Events
    • Webinars
    • Calendar
    • Annual Symposium
      • Annual Symposium 2022
      • Patiënteninformatiedag Gentherapie
    • Past events
      • Annual Symposium 2020-2021
      • Spring Symposium 2019
      • Spring Symposium 2018
  • Get Involved
    • Become a Member
    • Become a sponsor
    • Contact
  • Patient Info (NL)
    • Dossier Gentherapie Stichting BWM
    • Patiënteninformatiedag Gentherapie
    • Veelgestelde vragen
  • Sign in
Posted on 31/10/2018 by Enrico Mastrobattista

Biotechnologiebeleid bureau KLB

181015 Stand van de gedachtewisseling modernisering biotechnologiebeleid...
CategoriesUncategorized

Post navigation

Previous PostPrevious Cel- en gentherapie in opkomst maar toepassing kent belemmeringen – ZonMw
Next PostNext Chinese scientists are creating CRISPR babies

Aankomende activiteiten

There are no upcoming events.

View Calendar
Add
  • Add to Timely Calendar
  • Add to Google
  • Add to Outlook
  • Add to Apple Calendar
  • Add to other calendar
  • Export to XML
  • LinkedIn
Privacy Statement Proudly powered by WordPress